{
    "clinical_study": {
        "@rank": "38389", 
        "arm_group": {
            "arm_group_label": "SLE active flare", 
            "description": "Patients who are having an active flare of their lupus confirmed by labs"
        }, 
        "brief_summary": {
            "textblock": "The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for\n      myocardial inflammation."
        }, 
        "brief_title": "Myocardial Inflammation in Systemic Lupus Erythematosus", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "SLE", 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Lupus Erythematosus, Systemic", 
                "Myocarditis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The over-arching goal of this work is to further the understanding of myocardial damage in\n      systemic lupus erythematosus (SLE) using state of the art CV imaging to investigate a novel\n      potential mechanism of CV injury in SLE, subclinical myocardial inflammation.\n\n      Aim 1:  Investigate an alternative pathway for CV morbidity in SLE by measuring myocardial\n      edema at time of moderate to severe flare and compare values to post-flare studies and\n      historical healthy controls.\n\n      Hypothesis 1:  Myocardial edema, measured quantitatively with T2 CMR mapping during moderate\n      to severe SLE flare will be significantly increased compared to 1) historical controls and\n      2) in SLE patients after resolution of flare.\n\n      Aim 2:  Perform exploratory analyses investigating relationships between myocardial edema on\n      CMR and markers of SLE disease activity and CV risk factors.\n\n      Hypothesis 2:  Markers of disease activity including inflammatory makers (ESR and high\n      sensitivity c-reactive protein), complement and autoantibody levels will predict the\n      presence of T2 CMR detected myocardial edema during flare."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 Diagnosis of SLE by American College of Rheumatology Classification Criteria [21]\n\n               -  Active SLE Flare defined by Systemic Lupus Erythematosus Disease Activity Index\n                  (SLEDAI)[22] > 6 or British Isles Lupus Assessment Group (BILAG) Index A or\n                  B.[23]\n\n        Exclusion Criteria:\n\n          -  Pregnant\n\n          -  Allergy to gadolinium\n\n          -  Severe claustrophobia\n\n          -  Renal replacement therapy or glomerular filtration rate (GFR) < 30 mL/min/1.75m\u00b2\n\n          -  Medically unstable for transportation to Ross MRI scanner.  Stability will be defined\n             as: not on mechanical ventilation, HR < 120 BPM, MAP > 65 mmHg.  The treating\n             providers'  input on the patient's stability will also be considered in addition to\n             these criteria\n\n          -  Weight > 500 pounds\n\n          -  MR incompatible implanted devices such as neurostimulator pacemakers and implantable\n             defibrillators, presence of intracranial metal or any metal not compatible with CMR"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adults ages 18 years and older who are diagnosed with SLE"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761422", 
            "org_study_id": "2012H0132"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2014", 
        "location": {
            "contact": {
                "email": "amanda.kibler@osumc.edu", 
                "last_name": "Amanda S Kibler, BS", 
                "phone": "614-366-4982"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "OSUMC"
            }, 
            "investigator": {
                "last_name": "Stacy Ardoin, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Myocardial Inflammation in Systemic Lupus Erythematosus", 
        "overall_official": {
            "affiliation": "Ohio State University", 
            "last_name": "Stacy Ardoin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Compare T2 edema at flare and 3 months later", 
            "measure": "T2 edema on Cardiac MRI", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761422"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Ohio State University", 
            "investigator_full_name": "Stacy Ardoin MD", 
            "investigator_title": "Assistant Professor-Clinical", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stacy Ardoin MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}